At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 20 enrolled
Drug / intervention
PATH ID Adapterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase I Performance and Safety Evaluation of an Intradermal Delivery Device
In Brief
A Phase 1 clinical trial evaluating PATH ID Adapter for Injections, Intradermal. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate whether an investigational vaccine delivery device (the ID adapter) can safely and precisely inject liquid into the intradermal layer of the skin.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInjections, Intradermal
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2011
Primary CompletionMay 2011
First PostedMay 2011
TodayJul 2026
First PostedMay 24, 2011
Enrollment StartMay 1, 2011
Primary CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 15.1 years ago
Interventions
PATH ID Adapterdevice
Intradermal delivery device which fits on the end of a syringe to limit the depth and angle of needle penetration into the skin.